This company listing is no longer active
Nexstim Resultados de beneficios anteriores
Pasado controles de criterios 3/6
Información clave
42.4%
Tasa de crecimiento de los beneficios
79.1%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | 6.2% |
| Tasa de crecimiento de los ingresos | 34.5% |
| Rentabilidad financiera | 32.1% |
| Margen neto | 12.1% |
| Próxima actualización de resultados | 18 Aug 2023 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Nexstim. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 22 | 11 | 1 | 5 | 0 |
| 30 Sep 22 | 11 | 2 | 5 | 0 |
| 30 Jun 22 | 12 | 3 | 5 | 0 |
| 31 Mar 22 | 10 | 1 | 5 | 0 |
| 31 Dec 21 | 8 | -1 | 5 | 0 |
| 30 Sep 21 | 7 | -2 | 5 | 0 |
| 30 Jun 21 | 6 | -4 | 4 | 0 |
| 31 Mar 21 | 5 | -4 | 4 | 0 |
| 31 Dec 20 | 4 | -4 | 4 | 0 |
| 30 Sep 20 | 4 | -4 | 4 | 0 |
| 30 Jun 20 | 4 | -4 | 5 | 0 |
| 31 Mar 20 | 4 | -6 | 5 | 0 |
| 31 Dec 19 | 3 | -7 | 5 | 0 |
| 30 Sep 19 | 3 | -7 | 5 | 0 |
| 30 Jun 19 | 3 | -7 | 5 | 0 |
| 31 Mar 19 | 3 | -7 | 5 | 0 |
| 31 Dec 18 | 3 | -6 | 4 | 0 |
| 30 Sep 18 | 3 | -6 | 4 | 0 |
| 30 Jun 18 | 3 | -6 | 4 | 0 |
| 31 Mar 18 | 3 | -7 | 4 | 0 |
| 31 Dec 17 | 3 | -7 | 4 | 0 |
| 30 Sep 17 | 3 | -7 | 4 | 0 |
| 30 Jun 17 | 3 | -6 | 4 | 0 |
| 31 Mar 17 | 3 | -6 | 4 | 0 |
| 31 Dec 16 | 3 | -7 | 4 | 0 |
| 30 Sep 16 | 3 | -8 | 4 | 0 |
| 30 Jun 16 | 3 | -9 | 4 | 0 |
Ingresos de calidad: NXTMS has a high level of non-cash earnings.
Margen de beneficios creciente: NXTMS became profitable in the past.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: NXTMS has become profitable over the past 5 years, growing earnings by 42.4% per year.
Acelerando crecimiento: NXTMS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Beneficios vs. Industria: NXTMS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-5.6%).
Rentabilidad financiera
Alta ROE: NXTMS's Return on Equity (32.1%) is considered high.